全体要約
2023年の慢性心不全（CHF）デバイス市場は、推定で数百万米ドルの価値があり、2030年までに再調整された規模に達する見込みです。医療機器市場は2023年に6030億米ドルと推定され、今後6年間で年平均成長率（CAGR）5%で成長すると予測されています。高齢化社会の健康ニーズの増加や慢性疾患の蔓延が市場を牽引しています。
慢性心不全（CHF）デバイス市場は、販売量（Kユニット）と売上高（百万米ドル）で評価され、2019年から2030年までのデータが含まれています。市場は、インプラント型左心補助装置（LVAD）、両心室ペースメーカー、植込み型除細動器（ICD）などのタイプに分かれ、病院、クリニック、家庭などの用途に応じた分析が行われます。主要企業にはメドトロニック、アボット、ジョンソン・エンド・ジョンソンなどが含まれています。
関連する質問
Medtronic, Abbott, Johnson & Johnson, Stanley Pharmaceuticals, New Haven Pharmaceuticals, Inc., Boston Scientific Corporation, HeartWare, Biovail Corporation, Abiomed, Symplmed Pharmaceuticals, Berlin Heart GmbH, ReliantHeart, Inc., Cardiokinetix, Biotronik, Jarvik Heart
先進的医療サービスの需要増加, 医療技術の進歩, 高齢者人口の増加
概要
私たちの研究によると、2023年における世界の医療機器市場は6030億米ドルと推定され、今後6年間で年平均成長率（CAGR）5%で成長する見込みです。世界の医療費は世界のGDPの10%を占めており、高齢人口の健康ニーズの増加、慢性疾患や感染症の増加、そして新興市場の拡大により、近年継続的に増加しています。医療機器市場は医療業界において重要な役割を果たしています。この市場は、世界的な高度な医療サービスの需要増加、医療技術の進歩、高齢者人口の増加、医療費の上昇、早期の病気診断と治療に対する意識の高まりなど、いくつかの要因によって推進されています。
報告の範囲
本レポートは、慢性心不全（CHF）デバイスの世界市場に関する包括的なプレゼンテーションを提供することを目的としています。総販売量、販売収益、価格、主要企業の市場シェアおよびランキング、地域や国別、タイプ別、アプリケーション別の慢性心不全（CHF）デバイスの分析を含みます。
慢性心不全（CHF）デバイス市場の規模、推定、予測は、販売量（Kユニット）および販売収益（百万ドル）の観点から提供されており、2023年を基準年とし、2019年から2030年までの歴史的データと予測データが含まれています。定量的および定性的な分析を通じて、読者がビジネス/成長戦略を立て、市場競争状況を評価し、現在の市場における自らの位置を分析し、慢性心不全（CHF）デバイスに関する情報に基づいたビジネス判断を下す手助けをします。
市場セグメンテーション
会社別
メドトロニック
アボット
ジョンソン・エンド・ジョンソン
スタンレー製薬
ニューへイブンファーマシューティカルズ株式会社
ボストン・サイエンティフィック・コーポレーション
ハートウェア
バイオベイル社
アビオメッド
シンプルメッドファーマシューティカルズ
ベルリンハート社
リライアントハート株式会社
カーディオキネティクス
バイオトロニクス
ジャーヴィックハート
タイプ別セグメント：
植込み型左心室補助装置 (LVAD)
両心室ペースメーカー
植込み型除細動器（ICD）
持続的陽圧呼吸療法装置 (CPAP)
バイレベル陽圧呼吸療法装置 (BiPAP)
心臓ポンプ
アプリケーション別セグメント
病院
クリニック
家庭用品
その他
地域別
北アメリカ
アメリカ合衆国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋
中国
日本
韓国
中国 台湾
東南アジア
インド
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中東およびアフリカ
トルコ
サウジアラビア
UAE（アラブ首長国連邦）
章のアウトライン
第1章：報告の範囲、世界の市場規模（バルブ、数量、価格）を紹介します。この章では、市場の動向、市場の最新の発展、推進要因および制約要因、業界における製造業者が直面する課題とリスク、ならびに業界に関連する政策の分析も提供します。
第2章：慢性心不全（CHF）デバイスメーカーの競争環境、価格、販売および収益市場シェア、最新の開発計画、合併および買収情報などの詳細分析です。
第3章：各市場セグメントのタイプ別分析を提供し、各市場セグメントの市場規模と発展可能性をカバーします。これにより、読者は異なる市場セグメントでブルーオーシャン市場を見つける手助けをします。
第4章：アプリケーション別にさまざまな市場セグメントの分析を提供し、各市場セグメントの市場規模と発展潜力をカバーします。これにより、読者はさまざまな下流市場におけるブルーオーシャン市場を見つける手助けをします。
第5章：地域レベルにおける慢性心不全（CHF）デバイスの販売と収益。各地域の市場規模と発展の可能性に関する定量的な分析を提供し、世界各国の市場開発、将来の発展の展望、市場のスペースおよび市場規模を紹介します。
第6章：国別の慢性心不全（CHF）デバイスの販売および収益。各国/地域のタイプおよびアプリケーション別のシグマテデータを提供します。
第7章：主要プレイヤーのプロフィールを提供し、市場の主要企業の基本的な状況を詳細に紹介します。これには、製品の販売、収益、価格、粗利、製品紹介、最近の開発などが含まれます。
第8章: 産業チェーンの分析、業界の上流および下流を含む。
第9章：結論。
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 市場概要
1.1 慢性心不全（CHF）デバイス : プロダクトのイントロダクション
1.2 グローバルの市場規模、市場予測
1.2.1 グローバルの慢性心不全（CHF）デバイス売上規模、金額ベース（2019年～2030年）
1.2.2 グローバルの慢性心不全（CHF）デバイス売上規模、数量ベース（2019年～2030年）
1.2.3 グローバルの慢性心不全（CHF）デバイス市場、販売価格動向（2019年～2030年）
1.3 慢性心不全（CHF）デバイス市場トレンドと成長ドライバー
1.3.1 慢性心不全（CHF）デバイス業界トレンド
1.3.2 慢性心不全（CHF）デバイス市場のドライバーと事業機会
1.3.3 慢性心不全（CHF）デバイス市場の課題
1.3.4 慢性心不全（CHF）デバイス市場の抑制要因
1.4 前提条件と限界
1.5 調査の目的
1.6 対象年
2 競合分析、企業別
2.1 グローバルの慢性心不全（CHF）デバイス、プレイヤー収益ランキング（2023年）
2.2 グローバルにおける慢性心不全（CHF）デバイス市場の収益規模、企業別（2019年～2024年）
2.3 グローバルの慢性心不全（CHF）デバイス、プレイヤー売上数量ランキング（2023年）
2.4 グローバルの慢性心不全（CHF）デバイス、売上数量（企業別）（2019年～2024年）
2.5 グローバルの慢性心不全（CHF）デバイスの平均価格、企業別（2019年～2024年）
2.6 慢性心不全（CHF）デバイスの主要メーカー、製造・販売拠点およびヘッドクオーター
2.7 慢性心不全（CHF）デバイスの主要メーカー、製品展開
2.8 慢性心不全（CHF）デバイスの主要メーカー、量産開始時期
2.9 慢性心不全（CHF）デバイス市場の競争状況分析
2.9.1 慢性心不全（CHF）デバイス市場集中度比率（2019年～2024年）
2.9.2 グローバルの慢性心不全（CHF）デバイス、上位メーカー5～10社の収益（2023年）
2.9.3 グローバルの慢性心不全（CHF）デバイス、企業タイプ別上位メーカー（Tier 1、Tier 2、Tier 3）、2023年の収益ベース
2.10 M&A、拡大
3 セグメンテーション、タイプ別
3.1 イントロダクション、タイプ別
3.1.1 植込み型左室補助循環装置（LVAD）
3.1.2 両心室ペースメーカー
3.1.3 植込み型除細動器(ICD)
3.1.4 持続陽圧呼吸器 (CPAP)
3.1.5 バイレベル陽圧呼吸器 (BiPAP)
3.1.6 心臓ポンプ
3.2 グローバルの慢性心不全（CHF）デバイスの売上規模、金額ベース、タイプ別
3.2.1 グローバルの慢性心不全（CHF）デバイスの売上規模、金額ベース、タイプ別（2019年、2023年、2030年）
3.2.2 グローバルの慢性心不全（CHF）デバイスの売上規模、金額ベース、タイプ別（2019年～2030年）
3.2.3 グローバルの慢性心不全（CHF）デバイスの売上規模、金額ベース、タイプ別（%）（2019年～2030年）
3.3 グローバルの慢性心不全（CHF）デバイスの売上規模、数量ベース、タイプ別
3.3.1 グローバルの慢性心不全（CHF）デバイスの売上規模、数量ベース、タイプ別（2019年、2023年、2030年）
3.3.2 グローバルの慢性心不全（CHF）デバイスの売上規模、数量ベース、タイプ別（2019年～2030年）
3.3.3 グローバルの慢性心不全（CHF）デバイスの売上規模、数量ベース、タイプ別（%）（2019年～2030年）
3.4 グローバルの慢性心不全（CHF）デバイスの平均価格、タイプ別（2019年～2030年）
4 セグメンテーション、用途別
4.1 イントロダクション、用途別
4.1.1 病院
4.1.2 クリニック
4.1.3 家庭用
4.1.4 その他
4.2 グローバルの慢性心不全（CHF）デバイスの売上規模、金額ベース、用途別
4.2.1 グローバルの慢性心不全（CHF）デバイスの売上規模、金額ベース、用途別（2019年、2023年、2030年）
4.2.2 グローバルの慢性心不全（CHF）デバイスの売上規模、金額ベース、用途別（2019年～2030年）
4.2.3 グローバルの慢性心不全（CHF）デバイスの売上規模、金額ベース、用途別（%）（2019年～2030年）
4.3 グローバルの慢性心不全（CHF）デバイスの売上規模、数量ベース、用途別
4.3.1 グローバルの慢性心不全（CHF）デバイスの売上規模、数量ベース、用途別（2019年、2023年、2030年）
4.3.2 グローバルの慢性心不全（CHF）デバイスの売上規模、数量ベース、用途別（2019年～2030年）
4.3.3 グローバルの慢性心不全（CHF）デバイスの売上規模、数量ベース、用途別（%）（2019年～2030年）
4.4 グローバルの慢性心不全（CHF）デバイスの平均価格、用途別（2019年～2030年）
5 セグメンテーション、地域別
5.1 グローバルの慢性心不全（CHF）デバイスの売上規模、金額ベース、地域別
5.2 グローバルの慢性心不全（CHF）デバイスの売上規模、数量ベース、地域別
5.3 グローバルの慢性心不全（CHF）デバイスの平均価格、地域別（2019年～2030年）
5.4 北米
5.4.1 北米の慢性心不全（CHF）デバイス売上規模、金額ベース、2019年～2030年
5.4.2 北米の慢性心不全（CHF）デバイスの売上規模、金額ベース、国別（%）、2023年、2030年
5.5 ヨーロッパ
5.5.1 ヨーロッパの慢性心不全（CHF）デバイス売上規模、金額ベース、2019年～2030年
5.5.2 ヨーロッパの慢性心不全（CHF）デバイスの売上規模、金額ベース、国別（%）、2023年、2030年
5.6 アジア太平洋
5.6.1 アジア太平洋の慢性心不全（CHF）デバイス売上規模、金額ベース、2019年～2030年
5.6.2 アジア太平洋の慢性心不全（CHF）デバイスの売上規模、金額ベース、国別（%）、2023年、2030年
5.7 南米
5.7.1 南米の慢性心不全（CHF）デバイス売上規模、金額ベース、2019年～2030年
5.7.2 南米の慢性心不全（CHF）デバイスの売上規模、金額ベース、国別（%）、2023年、2030年
5.8 中東・アフリカ
5.8.1 中東・アフリカの慢性心不全（CHF）デバイス売上規模、金額ベース、2019年～2030年
5.8.2 中東・アフリカの慢性心不全（CHF）デバイスの売上規模、金額ベース、国別（%）、2023年、2030年
6 主要国・地域によるセグメンテーション
6.1 主要国・地域の慢性心不全（CHF）デバイスの売上成長トレンド、金額ベース（2019年、2023年、2030年）
6.2 主要国・地域の慢性心不全（CHF）デバイスの売上、金額ベース
6.3 米国
6.4 ヨーロッパ
6.5 中国
6.6 日本
6.7 韓国
6.8 東南アジア
6.9 インド
7 企業プロファイル
7.1 Medtronic
7.1.1 Medtronic：企業情報
7.1.2 Medtronicの紹介と事業概要
7.1.3 Medtronic：慢性心不全（CHF）デバイスの売上、収益および売上総利益率（2019年〜2024年）
7.1.4 Medtronic：慢性心不全（CHF）デバイス分野の提供製品
7.1.5 Medtronic直近の動向
7.2 Abbott
7.2.1 Abbott：企業情報
7.2.2 Abbottの紹介と事業概要
7.2.3 Abbott：慢性心不全（CHF）デバイスの売上、収益および売上総利益率（2019年〜2024年）
7.2.4 Abbott：慢性心不全（CHF）デバイス分野の提供製品
7.2.5 Abbott直近の動向
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson：企業情報
7.3.2 Johnson & Johnsonの紹介と事業概要
7.3.3 Johnson & Johnson：慢性心不全（CHF）デバイスの売上、収益および売上総利益率（2019年〜2024年）
7.3.4 Johnson & Johnson：慢性心不全（CHF）デバイス分野の提供製品
7.3.5 Johnson & Johnson直近の動向
7.4 Stanley Pharmaceuticals
7.4.1 Stanley Pharmaceuticals：企業情報
7.4.2 Stanley Pharmaceuticalsの紹介と事業概要
7.4.3 Stanley Pharmaceuticals：慢性心不全（CHF）デバイスの売上、収益および売上総利益率（2019年〜2024年）
7.4.4 Stanley Pharmaceuticals：慢性心不全（CHF）デバイス分野の提供製品
7.4.5 Stanley Pharmaceuticals直近の動向
7.5 New Haven Pharmaceuticals, Inc
7.6 Boston Scientific Corporation
7.6.1 Boston Scientific Corporation：企業情報
7.6.2 Boston Scientific Corporationの紹介と事業概要
7.6.3 Boston Scientific Corporation：慢性心不全（CHF）デバイスの売上、収益および売上総利益率（2019年〜2024年）
7.6.4 Boston Scientific Corporation：慢性心不全（CHF）デバイス分野の提供製品
7.6.5 Boston Scientific Corporation直近の動向
7.7 HeartWare
7.7.1 HeartWare：企業情報
7.7.2 HeartWareの紹介と事業概要
7.7.3 HeartWare：慢性心不全（CHF）デバイスの売上、収益および売上総利益率（2019年〜2024年）
7.7.4 HeartWare：慢性心不全（CHF）デバイス分野の提供製品
7.7.5 HeartWare直近の動向
7.8 Biovail Corporation
7.8.1 Biovail Corporation：企業情報
7.8.2 Biovail Corporationの紹介と事業概要
7.8.3 Biovail Corporation：慢性心不全（CHF）デバイスの売上、収益および売上総利益率（2019年〜2024年）
7.8.4 Biovail Corporation：慢性心不全（CHF）デバイス分野の提供製品
7.8.5 Biovail Corporation直近の動向
7.9 Abiomed
7.9.1 Abiomed：企業情報
7.9.2 Abiomedの紹介と事業概要
7.9.3 Abiomed：慢性心不全（CHF）デバイスの売上、収益および売上総利益率（2019年〜2024年）
7.9.4 Abiomed：慢性心不全（CHF）デバイス分野の提供製品
7.9.5 Abiomed直近の動向
7.10 Symplmed Pharmaceuticals
7.10.1 Symplmed Pharmaceuticals：企業情報
7.10.2 Symplmed Pharmaceuticalsの紹介と事業概要
7.10.3 Symplmed Pharmaceuticals：慢性心不全（CHF）デバイスの売上、収益および売上総利益率（2019年〜2024年）
7.10.4 Symplmed Pharmaceuticals：慢性心不全（CHF）デバイス分野の提供製品
7.10.5 Symplmed Pharmaceuticals直近の動向
7.11 Berlin Heart GmbH
7.11.1 Berlin Heart GmbH：企業情報
7.11.2 Berlin Heart GmbHの紹介と事業概要
7.11.3 Berlin Heart GmbH：慢性心不全（CHF）デバイスの売上、収益および売上総利益率（2019年〜2024年）
7.11.4 Berlin Heart GmbH：慢性心不全（CHF）デバイス分野の提供製品
7.11.5 Berlin Heart GmbH直近の動向
7.12 ReliantHeart, Inc
7.13 Cardiokinetix
7.13.1 Cardiokinetix：企業情報
7.13.2 Cardiokinetixの紹介と事業概要
7.13.3 Cardiokinetix：慢性心不全（CHF）デバイスの売上、収益および売上総利益率（2019年〜2024年）
7.13.4 Cardiokinetix：慢性心不全（CHF）デバイス分野の提供製品
7.13.5 Cardiokinetix直近の動向
7.14 Biotronik
7.14.1 Biotronik：企業情報
7.14.2 Biotronikの紹介と事業概要
7.14.3 Biotronik：慢性心不全（CHF）デバイスの売上、収益および売上総利益率（2019年〜2024年）
7.14.4 Biotronik：慢性心不全（CHF）デバイス分野の提供製品
7.14.5 Biotronik直近の動向
7.15 Jarvik Heart
7.15.1 Jarvik Heart：企業情報
7.15.2 Jarvik Heartの紹介と事業概要
7.15.3 Jarvik Heart：慢性心不全（CHF）デバイスの売上、収益および売上総利益率（2019年〜2024年）
7.15.4 Jarvik Heart：慢性心不全（CHF）デバイス分野の提供製品
7.15.5 Jarvik Heart直近の動向
8 業界チェーン分析
8.1 慢性心不全（CHF）デバイス業界バリューチェーン
8.2 慢性心不全（CHF）デバイス市場の上流分析
8.2.1 主要原材料
8.2.2 原材料と主要サプライヤー
8.2.3 製造コスト構造
8.3 中流分析
8.4 下流分析（顧客についての分析）
8.5 営業販売モデル、販売チャネル
8.5.1 慢性心不全（CHF）デバイス 営業販売モデル
8.5.2 販売チャネル
8.5.3 慢性心不全（CHF）デバイスの流通業者
9 調査の結果・結論
10 付録
10.1 調査手法
10.1.1 調査手法 / 調査アプローチ
10.1.2 データソース
10.2 執筆者の詳細
10.3 免責事項
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Chronic Heart Failure (CHF) Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Chronic Heart Failure (CHF) Devices by region & country, by Type, and by Application.
The Chronic Heart Failure (CHF) Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Heart Failure (CHF) Devices.
Market Segmentation
By Company
Medtronic
Abbott
Johnson & Johnson
Stanley Pharmaceuticals
New Haven Pharmaceuticals, Inc.
Boston Scientific Corporation
HeartWare
Biovail Corporation
Abiomed
Symplmed Pharmaceuticals
Berlin Heart GmbH
ReliantHeart, Inc.
Cardiokinetix
Biotronik
Jarvik Heart
Segment by Type:
Implantable Left Ventricular Assist Device (LVAD)
Biventricular Pacemaker
Implantable Cardioverter-defibrillators (ICDs)
Continuous Positive Air Pressure Device (CPAP)
Bi-level Positive Air Pressure Device (BiPAP)
Heart Pumps
Segment by Application
Hospital
Clinic
Household
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Chronic Heart Failure (CHF) Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Chronic Heart Failure (CHF) Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Chronic Heart Failure (CHF) Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Chronic Heart Failure (CHF) Devices Product Introduction
1.2 Global Chronic Heart Failure (CHF) Devices Market Size Forecast
1.2.1 Global Chronic Heart Failure (CHF) Devices Sales Value (2019-2030)
1.2.2 Global Chronic Heart Failure (CHF) Devices Sales Volume (2019-2030)
1.2.3 Global Chronic Heart Failure (CHF) Devices Sales Price (2019-2030)
1.3 Chronic Heart Failure (CHF) Devices Market Trends & Drivers
1.3.1 Chronic Heart Failure (CHF) Devices Industry Trends
1.3.2 Chronic Heart Failure (CHF) Devices Market Drivers & Opportunity
1.3.3 Chronic Heart Failure (CHF) Devices Market Challenges
1.3.4 Chronic Heart Failure (CHF) Devices Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Chronic Heart Failure (CHF) Devices Players Revenue Ranking (2023)
2.2 Global Chronic Heart Failure (CHF) Devices Revenue by Company (2019-2024)
2.3 Global Chronic Heart Failure (CHF) Devices Players Sales Volume Ranking (2023)
2.4 Global Chronic Heart Failure (CHF) Devices Sales Volume by Company Players (2019-2024)
2.5 Global Chronic Heart Failure (CHF) Devices Average Price by Company (2019-2024)
2.6 Key Manufacturers Chronic Heart Failure (CHF) Devices Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Chronic Heart Failure (CHF) Devices Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Chronic Heart Failure (CHF) Devices
2.9 Chronic Heart Failure (CHF) Devices Market Competitive Analysis
2.9.1 Chronic Heart Failure (CHF) Devices Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Chronic Heart Failure (CHF) Devices Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Heart Failure (CHF) Devices as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Implantable Left Ventricular Assist Device (LVAD)
3.1.2 Biventricular Pacemaker
3.1.3 Implantable Cardioverter-defibrillators (ICDs)
3.1.4 Continuous Positive Air Pressure Device (CPAP)
3.1.5 Bi-level Positive Air Pressure Device (BiPAP)
3.1.6 Heart Pumps
3.2 Global Chronic Heart Failure (CHF) Devices Sales Value by Type
3.2.1 Global Chronic Heart Failure (CHF) Devices Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Chronic Heart Failure (CHF) Devices Sales Value, by Type (2019-2030)
3.2.3 Global Chronic Heart Failure (CHF) Devices Sales Value, by Type (%) (2019-2030)
3.3 Global Chronic Heart Failure (CHF) Devices Sales Volume by Type
3.3.1 Global Chronic Heart Failure (CHF) Devices Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Chronic Heart Failure (CHF) Devices Sales Volume, by Type (2019-2030)
3.3.3 Global Chronic Heart Failure (CHF) Devices Sales Volume, by Type (%) (2019-2030)
3.4 Global Chronic Heart Failure (CHF) Devices Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Household
4.1.4 Others
4.2 Global Chronic Heart Failure (CHF) Devices Sales Value by Application
4.2.1 Global Chronic Heart Failure (CHF) Devices Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Chronic Heart Failure (CHF) Devices Sales Value, by Application (2019-2030)
4.2.3 Global Chronic Heart Failure (CHF) Devices Sales Value, by Application (%) (2019-2030)
4.3 Global Chronic Heart Failure (CHF) Devices Sales Volume by Application
4.3.1 Global Chronic Heart Failure (CHF) Devices Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Chronic Heart Failure (CHF) Devices Sales Volume, by Application (2019-2030)
4.3.3 Global Chronic Heart Failure (CHF) Devices Sales Volume, by Application (%) (2019-2030)
4.4 Global Chronic Heart Failure (CHF) Devices Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Chronic Heart Failure (CHF) Devices Sales Value by Region
5.1.1 Global Chronic Heart Failure (CHF) Devices Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Chronic Heart Failure (CHF) Devices Sales Value by Region (2019-2024)
5.1.3 Global Chronic Heart Failure (CHF) Devices Sales Value by Region (2025-2030)
5.1.4 Global Chronic Heart Failure (CHF) Devices Sales Value by Region (%), (2019-2030)
5.2 Global Chronic Heart Failure (CHF) Devices Sales Volume by Region
5.2.1 Global Chronic Heart Failure (CHF) Devices Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Chronic Heart Failure (CHF) Devices Sales Volume by Region (2019-2024)
5.2.3 Global Chronic Heart Failure (CHF) Devices Sales Volume by Region (2025-2030)
5.2.4 Global Chronic Heart Failure (CHF) Devices Sales Volume by Region (%), (2019-2030)
5.3 Global Chronic Heart Failure (CHF) Devices Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Chronic Heart Failure (CHF) Devices Sales Value, 2019-2030
5.4.2 North America Chronic Heart Failure (CHF) Devices Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Chronic Heart Failure (CHF) Devices Sales Value, 2019-2030
5.5.2 Europe Chronic Heart Failure (CHF) Devices Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Chronic Heart Failure (CHF) Devices Sales Value, 2019-2030
5.6.2 Asia Pacific Chronic Heart Failure (CHF) Devices Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Chronic Heart Failure (CHF) Devices Sales Value, 2019-2030
5.7.2 South America Chronic Heart Failure (CHF) Devices Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Value, 2019-2030
5.8.2 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Chronic Heart Failure (CHF) Devices Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Chronic Heart Failure (CHF) Devices Sales Value
6.2.1 Key Countries/Regions Chronic Heart Failure (CHF) Devices Sales Value, 2019-2030
6.2.2 Key Countries/Regions Chronic Heart Failure (CHF) Devices Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Chronic Heart Failure (CHF) Devices Sales Value, 2019-2030
6.3.2 United States Chronic Heart Failure (CHF) Devices Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Chronic Heart Failure (CHF) Devices Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Chronic Heart Failure (CHF) Devices Sales Value, 2019-2030
6.4.2 Europe Chronic Heart Failure (CHF) Devices Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Chronic Heart Failure (CHF) Devices Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Chronic Heart Failure (CHF) Devices Sales Value, 2019-2030
6.5.2 China Chronic Heart Failure (CHF) Devices Sales Value by Type (%), 2023 VS 2030
6.5.3 China Chronic Heart Failure (CHF) Devices Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Chronic Heart Failure (CHF) Devices Sales Value, 2019-2030
6.6.2 Japan Chronic Heart Failure (CHF) Devices Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Chronic Heart Failure (CHF) Devices Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Chronic Heart Failure (CHF) Devices Sales Value, 2019-2030
6.7.2 South Korea Chronic Heart Failure (CHF) Devices Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Chronic Heart Failure (CHF) Devices Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Chronic Heart Failure (CHF) Devices Sales Value, 2019-2030
6.8.2 Southeast Asia Chronic Heart Failure (CHF) Devices Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Chronic Heart Failure (CHF) Devices Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Chronic Heart Failure (CHF) Devices Sales Value, 2019-2030
6.9.2 India Chronic Heart Failure (CHF) Devices Sales Value by Type (%), 2023 VS 2030
6.9.3 India Chronic Heart Failure (CHF) Devices Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Introduction and Business Overview
7.1.3 Medtronic Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Medtronic Chronic Heart Failure (CHF) Devices Product Offerings
7.1.5 Medtronic Recent Development
7.2 Abbott
7.2.1 Abbott Company Information
7.2.2 Abbott Introduction and Business Overview
7.2.3 Abbott Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Abbott Chronic Heart Failure (CHF) Devices Product Offerings
7.2.5 Abbott Recent Development
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Information
7.3.2 Johnson & Johnson Introduction and Business Overview
7.3.3 Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Johnson & Johnson Chronic Heart Failure (CHF) Devices Product Offerings
7.3.5 Johnson & Johnson Recent Development
7.4 Stanley Pharmaceuticals
7.4.1 Stanley Pharmaceuticals Company Information
7.4.2 Stanley Pharmaceuticals Introduction and Business Overview
7.4.3 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Offerings
7.4.5 Stanley Pharmaceuticals Recent Development
7.5 New Haven Pharmaceuticals, Inc.
7.5.1 New Haven Pharmaceuticals, Inc. Company Information
7.5.2 New Haven Pharmaceuticals, Inc. Introduction and Business Overview
7.5.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.5.4 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Product Offerings
7.5.5 New Haven Pharmaceuticals, Inc. Recent Development
7.6 Boston Scientific Corporation
7.6.1 Boston Scientific Corporation Company Information
7.6.2 Boston Scientific Corporation Introduction and Business Overview
7.6.3 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Product Offerings
7.6.5 Boston Scientific Corporation Recent Development
7.7 HeartWare
7.7.1 HeartWare Company Information
7.7.2 HeartWare Introduction and Business Overview
7.7.3 HeartWare Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.7.4 HeartWare Chronic Heart Failure (CHF) Devices Product Offerings
7.7.5 HeartWare Recent Development
7.8 Biovail Corporation
7.8.1 Biovail Corporation Company Information
7.8.2 Biovail Corporation Introduction and Business Overview
7.8.3 Biovail Corporation Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Biovail Corporation Chronic Heart Failure (CHF) Devices Product Offerings
7.8.5 Biovail Corporation Recent Development
7.9 Abiomed
7.9.1 Abiomed Company Information
7.9.2 Abiomed Introduction and Business Overview
7.9.3 Abiomed Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Abiomed Chronic Heart Failure (CHF) Devices Product Offerings
7.9.5 Abiomed Recent Development
7.10 Symplmed Pharmaceuticals
7.10.1 Symplmed Pharmaceuticals Company Information
7.10.2 Symplmed Pharmaceuticals Introduction and Business Overview
7.10.3 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Offerings
7.10.5 Symplmed Pharmaceuticals Recent Development
7.11 Berlin Heart GmbH
7.11.1 Berlin Heart GmbH Company Information
7.11.2 Berlin Heart GmbH Introduction and Business Overview
7.11.3 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Product Offerings
7.11.5 Berlin Heart GmbH Recent Development
7.12 ReliantHeart, Inc.
7.12.1 ReliantHeart, Inc. Company Information
7.12.2 ReliantHeart, Inc. Introduction and Business Overview
7.12.3 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.12.4 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Product Offerings
7.12.5 ReliantHeart, Inc. Recent Development
7.13 Cardiokinetix
7.13.1 Cardiokinetix Company Information
7.13.2 Cardiokinetix Introduction and Business Overview
7.13.3 Cardiokinetix Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Cardiokinetix Chronic Heart Failure (CHF) Devices Product Offerings
7.13.5 Cardiokinetix Recent Development
7.14 Biotronik
7.14.1 Biotronik Company Information
7.14.2 Biotronik Introduction and Business Overview
7.14.3 Biotronik Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Biotronik Chronic Heart Failure (CHF) Devices Product Offerings
7.14.5 Biotronik Recent Development
7.15 Jarvik Heart
7.15.1 Jarvik Heart Company Information
7.15.2 Jarvik Heart Introduction and Business Overview
7.15.3 Jarvik Heart Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Jarvik Heart Chronic Heart Failure (CHF) Devices Product Offerings
7.15.5 Jarvik Heart Recent Development
8 Industry Chain Analysis
8.1 Chronic Heart Failure (CHF) Devices Industrial Chain
8.2 Chronic Heart Failure (CHF) Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Chronic Heart Failure (CHF) Devices Sales Model
8.5.2 Sales Channel
8.5.3 Chronic Heart Failure (CHF) Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables Table 1. Chronic Heart Failure (CHF) Devices Market Trends Table 2. Chronic Heart Failure (CHF) Devices Market Drivers & Opportunity Table 3. Chronic Heart Failure (CHF) Devices Market Challenges Table 4. Chronic Heart Failure (CHF) Devices Market Restraints Table 5. Global Chronic Heart Failure (CHF) Devices Revenue by Company (2019-2024) & (US$ Million) Table 6. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Company (2019-2024) Table 7. Global Chronic Heart Failure (CHF) Devices Sales Volume by Company (2019-2024) & (K Units) Table 8. Global Chronic Heart Failure (CHF) Devices Sales Volume Market Share by Company (2019-2024) Table 9. Global Market Chronic Heart Failure (CHF) Devices Price by Company (2019-2024) & (US$/Unit) Table 10. Key Manufacturers Chronic Heart Failure (CHF) Devices Manufacturing Base Distribution and Headquarters Table 11. Key Manufacturers Chronic Heart Failure (CHF) Devices Product Type Table 12. Key Manufacturers Time to Begin Mass Production of Chronic Heart Failure (CHF) Devices Table 13. Global Chronic Heart Failure (CHF) Devices Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Heart Failure (CHF) Devices as of 2023) Table 15. Mergers & Acquisitions, Expansion Plans Table 16. Global Chronic Heart Failure (CHF) Devices Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million) Table 17. Global Chronic Heart Failure (CHF) Devices Sales Value by Type (2019-2024) & (US$ Million) Table 18. Global Chronic Heart Failure (CHF) Devices Sales Value by Type (2025-2030) & (US$ Million) Table 19. Global Chronic Heart Failure (CHF) Devices Sales Market Share in Value by Type (2019-2024) & (%) Table 20. Global Chronic Heart Failure (CHF) Devices Sales Market Share in Value by Type (2025-2030) & (%) Table 21. Global Chronic Heart Failure (CHF) Devices Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units) Table 22. Global Chronic Heart Failure (CHF) Devices Sales Volume by Type (2019-2024) & (K Units) Table 23. Global Chronic Heart Failure (CHF) Devices Sales Volume by Type (2025-2030) & (K Units) Table 24. Global Chronic Heart Failure (CHF) Devices Sales Market Share in Volume by Type (2019-2024) & (%) Table 25. Global Chronic Heart Failure (CHF) Devices Sales Market Share in Volume by Type (2025-2030) & (%) Table 26. Global Chronic Heart Failure (CHF) Devices Price by Type (2019-2024) & (US$/Unit) Table 27. Global Chronic Heart Failure (CHF) Devices Price by Type (2025-2030) & (US$/Unit) Table 28. Global Chronic Heart Failure (CHF) Devices Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million) Table 29. Global Chronic Heart Failure (CHF) Devices Sales Value by Application (2019-2024) & (US$ Million) Table 30. Global Chronic Heart Failure (CHF) Devices Sales Value by Application (2025-2030) & (US$ Million) Table 31. Global Chronic Heart Failure (CHF) Devices Sales Market Share in Value by Application (2019-2024) & (%) Table 32. Global Chronic Heart Failure (CHF) Devices Sales Market Share in Value by Application (2025-2030) & (%) Table 33. Global Chronic Heart Failure (CHF) Devices Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units) Table 34. Global Chronic Heart Failure (CHF) Devices Sales Volume by Application (2019-2024) & (K Units) Table 35. Global Chronic Heart Failure (CHF) Devices Sales Volume by Application (2025-2030) & (K Units) Table 36. Global Chronic Heart Failure (CHF) Devices Sales Market Share in Volume by Application (2019-2024) & (%) Table 37. Global Chronic Heart Failure (CHF) Devices Sales Market Share in Volume by Application (2025-2030) & (%) Table 38. Global Chronic Heart Failure (CHF) Devices Price by Application (2019-2024) & (US$/Unit) Table 39. Global Chronic Heart Failure (CHF) Devices Price by Application (2025-2030) & (US$/Unit) Table 40. Global Chronic Heart Failure (CHF) Devices Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 41. Global Chronic Heart Failure (CHF) Devices Sales Value by Region (2019-2024) & (US$ Million) Table 42. Global Chronic Heart Failure (CHF) Devices Sales Value by Region (2025-2030) & (US$ Million) Table 43. Global Chronic Heart Failure (CHF) Devices Sales Value by Region (2019-2024) & (%) Table 44. Global Chronic Heart Failure (CHF) Devices Sales Value by Region (2025-2030) & (%) Table 45. Global Chronic Heart Failure (CHF) Devices Sales Volume by Region (K Units): 2019 VS 2023 VS 2030 Table 46. Global Chronic Heart Failure (CHF) Devices Sales Volume by Region (2019-2024) & (K Units) Table 47. Global Chronic Heart Failure (CHF) Devices Sales Volume by Region (2025-2030) & (K Units) Table 48. Global Chronic Heart Failure (CHF) Devices Sales Volume by Region (2019-2024) & (%) Table 49. Global Chronic Heart Failure (CHF) Devices Sales Volume by Region (2025-2030) & (%) Table 50. Global Chronic Heart Failure (CHF) Devices Average Price by Region (2019-2024) & (US$/Unit) Table 51. Global Chronic Heart Failure (CHF) Devices Average Price by Region (2025-2030) & (US$/Unit) Table 52. Key Countries/Regions Chronic Heart Failure (CHF) Devices Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030 Table 53. Key Countries/Regions Chronic Heart Failure (CHF) Devices Sales Value, (2019-2024) & (US$ Million) Table 54. Key Countries/Regions Chronic Heart Failure (CHF) Devices Sales Value, (2025-2030) & (US$ Million) Table 55. Key Countries/Regions Chronic Heart Failure (CHF) Devices Sales Volume, (2019-2024) & (K Units) Table 56. Key Countries/Regions Chronic Heart Failure (CHF) Devices Sales Volume, (2025-2030) & (K Units) Table 57. Medtronic Company Information Table 58. Medtronic Introduction and Business Overview Table 59. Medtronic Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 60. Medtronic Chronic Heart Failure (CHF) Devices Product Offerings Table 61. Medtronic Recent Development Table 62. Abbott Company Information Table 63. Abbott Introduction and Business Overview Table 64. Abbott Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 65. Abbott Chronic Heart Failure (CHF) Devices Product Offerings Table 66. Abbott Recent Development Table 67. Johnson & Johnson Company Information Table 68. Johnson & Johnson Introduction and Business Overview Table 69. Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 70. Johnson & Johnson Chronic Heart Failure (CHF) Devices Product Offerings Table 71. Johnson & Johnson Recent Development Table 72. Stanley Pharmaceuticals Company Information Table 73. Stanley Pharmaceuticals Introduction and Business Overview Table 74. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 75. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Offerings Table 76. Stanley Pharmaceuticals Recent Development Table 77. New Haven Pharmaceuticals, Inc. Company Information Table 78. New Haven Pharmaceuticals, Inc. Introduction and Business Overview Table 79. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 80. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Product Offerings Table 81. New Haven Pharmaceuticals, Inc. Recent Development Table 82. Boston Scientific Corporation Company Information Table 83. Boston Scientific Corporation Introduction and Business Overview Table 84. Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 85. Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Product Offerings Table 86. Boston Scientific Corporation Recent Development Table 87. HeartWare Company Information Table 88. HeartWare Introduction and Business Overview Table 89. HeartWare Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 90. HeartWare Chronic Heart Failure (CHF) Devices Product Offerings Table 91. HeartWare Recent Development Table 92. Biovail Corporation Company Information Table 93. Biovail Corporation Introduction and Business Overview Table 94. Biovail Corporation Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 95. Biovail Corporation Chronic Heart Failure (CHF) Devices Product Offerings Table 96. Biovail Corporation Recent Development Table 97. Abiomed Company Information Table 98. Abiomed Introduction and Business Overview Table 99. Abiomed Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 100. Abiomed Chronic Heart Failure (CHF) Devices Product Offerings Table 101. Abiomed Recent Development Table 102. Symplmed Pharmaceuticals Company Information Table 103. Symplmed Pharmaceuticals Introduction and Business Overview Table 104. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 105. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Offerings Table 106. Symplmed Pharmaceuticals Recent Development Table 107. Berlin Heart GmbH Company Information Table 108. Berlin Heart GmbH Introduction and Business Overview Table 109. Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 110. Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Product Offerings Table 111. Berlin Heart GmbH Recent Development Table 112. ReliantHeart, Inc. Company Information Table 113. ReliantHeart, Inc. Introduction and Business Overview Table 114. ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 115. ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Product Offerings Table 116. ReliantHeart, Inc. Recent Development Table 117. Cardiokinetix Company Information Table 118. Cardiokinetix Introduction and Business Overview Table 119. Cardiokinetix Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 120. Cardiokinetix Chronic Heart Failure (CHF) Devices Product Offerings Table 121. Cardiokinetix Recent Development Table 122. Biotronik Company Information Table 123. Biotronik Introduction and Business Overview Table 124. Biotronik Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 125. Biotronik Chronic Heart Failure (CHF) Devices Product Offerings Table 126. Biotronik Recent Development Table 127. Jarvik Heart Company Information Table 128. Jarvik Heart Introduction and Business Overview Table 129. Jarvik Heart Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 130. Jarvik Heart Chronic Heart Failure (CHF) Devices Product Offerings Table 131. Jarvik Heart Recent Development Table 132. Key Raw Materials Lists Table 133. Raw Materials Key Suppliers Lists Table 134. Chronic Heart Failure (CHF) Devices Downstream Customers Table 135. Chronic Heart Failure (CHF) Devices Distributors List Table 136. Research Programs/Design for This Report Table 137. Key Data Information from Secondary Sources Table 138. Key Data Information from Primary Sources List of Figures Figure 1. Chronic Heart Failure (CHF) Devices Product Picture Figure 2. Global Chronic Heart Failure (CHF) Devices Sales Value, 2019 VS 2023 VS 2030 (US$ Million) Figure 3. Global Chronic Heart Failure (CHF) Devices Sales Value (2019-2030) & (US$ Million) Figure 4. Global Chronic Heart Failure (CHF) Devices Sales Volume (2019-2030) & (K Units) Figure 5. Global Chronic Heart Failure (CHF) Devices Sales Price (2019-2030) & (US$/Unit) Figure 6. Chronic Heart Failure (CHF) Devices Report Years Considered Figure 7. Global Chronic Heart Failure (CHF) Devices Players Revenue Ranking (2023) & (US$ Million) Figure 8. Global Chronic Heart Failure (CHF) Devices Players Sales Volume Ranking (2023) & (K Units) Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Chronic Heart Failure (CHF) Devices Revenue in 2023 Figure 10. Chronic Heart Failure (CHF) Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 Figure 11. Implantable Left Ventricular Assist Device (LVAD) Picture Figure 12. Biventricular Pacemaker Picture Figure 13. Implantable Cardioverter-defibrillators (ICDs) Picture Figure 14. Continuous Positive Air Pressure Device (CPAP) Picture Figure 15. Bi-level Positive Air Pressure Device (BiPAP) Picture Figure 16. Heart Pumps Picture Figure 17. Global Chronic Heart Failure (CHF) Devices Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million) Figure 18. Global Chronic Heart Failure (CHF) Devices Sales Value Market Share by Type, 2023 & 2030 Figure 19. Global Chronic Heart Failure (CHF) Devices Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units) Figure 20. Global Chronic Heart Failure (CHF) Devices Sales Volume Market Share by Type, 2023 & 2030 Figure 21. Global Chronic Heart Failure (CHF) Devices Price by Type (2019-2030) & (US$/Unit) Figure 22. Product Picture of Hospital Figure 23. Product Picture of Clinic Figure 24. Product Picture of Household Figure 25. Product Picture of Others Figure 26. Global Chronic Heart Failure (CHF) Devices Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million) Figure 27. Global Chronic Heart Failure (CHF) Devices Sales Value Market Share by Application, 2023 & 2030 Figure 28. Global Chronic Heart Failure (CHF) Devices Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units) Figure 29. Global Chronic Heart Failure (CHF) Devices Sales Volume Market Share by Application, 2023 & 2030 Figure 30. Global Chronic Heart Failure (CHF) Devices Price by Application (2019-2030) & (US$/Unit) Figure 31. North America Chronic Heart Failure (CHF) Devices Sales Value (2019-2030) & (US$ Million) Figure 32. North America Chronic Heart Failure (CHF) Devices Sales Value by Country (%), 2023 VS 2030 Figure 33. Europe Chronic Heart Failure (CHF) Devices Sales Value (2019-2030) & (US$ Million) Figure 34. Europe Chronic Heart Failure (CHF) Devices Sales Value by Country (%), 2023 VS 2030 Figure 35. Asia Pacific Chronic Heart Failure (CHF) Devices Sales Value (2019-2030) & (US$ Million) Figure 36. Asia Pacific Chronic Heart Failure (CHF) Devices Sales Value by Country (%), 2023 VS 2030 Figure 37. South America Chronic Heart Failure (CHF) Devices Sales Value (2019-2030) & (US$ Million) Figure 38. South America Chronic Heart Failure (CHF) Devices Sales Value by Country (%), 2023 VS 2030 Figure 39. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Value (2019-2030) & (US$ Million) Figure 40. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Value by Country (%), 2023 VS 2030 Figure 41. Key Countries/Regions Chronic Heart Failure (CHF) Devices Sales Value (%), (2019-2030) Figure 42. Key Countries/Regions Chronic Heart Failure (CHF) Devices Sales Volume (%), (2019-2030) Figure 43. United States Chronic Heart Failure (CHF) Devices Sales Value, (2019-2030) & (US$ Million) Figure 44. United States Chronic Heart Failure (CHF) Devices Sales Value by Type (%), 2023 VS 2030 Figure 45. United States Chronic Heart Failure (CHF) Devices Sales Value by Application (%), 2023 VS 2030 Figure 46. Europe Chronic Heart Failure (CHF) Devices Sales Value, (2019-2030) & (US$ Million) Figure 47. Europe Chronic Heart Failure (CHF) Devices Sales Value by Type (%), 2023 VS 2030 Figure 48. Europe Chronic Heart Failure (CHF) Devices Sales Value by Application (%), 2023 VS 2030 Figure 49. China Chronic Heart Failure (CHF) Devices Sales Value, (2019-2030) & (US$ Million) Figure 50. China Chronic Heart Failure (CHF) Devices Sales Value by Type (%), 2023 VS 2030 Figure 51. China Chronic Heart Failure (CHF) Devices Sales Value by Application (%), 2023 VS 2030 Figure 52. Japan Chronic Heart Failure (CHF) Devices Sales Value, (2019-2030) & (US$ Million) Figure 53. Japan Chronic Heart Failure (CHF) Devices Sales Value by Type (%), 2023 VS 2030 Figure 54. Japan Chronic Heart Failure (CHF) Devices Sales Value by Application (%), 2023 VS 2030 Figure 55. South Korea Chronic Heart Failure (CHF) Devices Sales Value, (2019-2030) & (US$ Million) Figure 56. South Korea Chronic Heart Failure (CHF) Devices Sales Value by Type (%), 2023 VS 2030 Figure 57. South Korea Chronic Heart Failure (CHF) Devices Sales Value by Application (%), 2023 VS 2030 Figure 58. Southeast Asia Chronic Heart Failure (CHF) Devices Sales Value, (2019-2030) & (US$ Million) Figure 59. Southeast Asia Chronic Heart Failure (CHF) Devices Sales Value by Type (%), 2023 VS 2030 Figure 60. Southeast Asia Chronic Heart Failure (CHF) Devices Sales Value by Application (%), 2023 VS 2030 Figure 61. India Chronic Heart Failure (CHF) Devices Sales Value, (2019-2030) & (US$ Million) Figure 62. India Chronic Heart Failure (CHF) Devices Sales Value by Type (%), 2023 VS 2030 Figure 63. India Chronic Heart Failure (CHF) Devices Sales Value by Application (%), 2023 VS 2030 Figure 64. Chronic Heart Failure (CHF) Devices Industrial Chain Figure 65. Chronic Heart Failure (CHF) Devices Manufacturing Cost Structure Figure 66. Channels of Distribution (Direct Sales, and Distribution) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed
